Buy 2F-DCK 50 mg Pellets – Premium Dissociative Research Chemical | euro-labchems.com

Buy 2F-DCK 50 mg Pellets (2-Fluorodeschloroketamine) CAS Number: 111982-49-1 (freebase reference; HCl salt variant) Molecular Formula: C₁₃H₁₆FNO • HCl Molecular Weight: 257.73 g/mol Purity: ≥98.5% (HPLC verified) Dosage per pellet: Exactly 50 mg 2F-DCK Form: Compressed pharmaceutical-grade pellets (uniform, scored for precision) Quantity options: 10, 20, 50, 100 pellets Shipping: Discreet worldwide, vacuum-sealed, moisture-proof packaging

euro-labchems.com offers high-quality 2F-DCK 50 mg pellets – a novel arylcyclohexylamine dissociative and close structural analog of ketamine. As 2-fluorodeschloroketamine, 2F-DCK replaces ketamine’s chlorine with fluorine, serving as a valuable tool for pharmacological, neurochemical, and behavioral research on NMDA receptor antagonism and dissociative mechanisms.

What is 2F-DCK?

2F-DCK (2-(2-fluorophenyl)-2-(methylamino)cyclohexan-1-one) is a designer dissociative anesthetic presumed to act primarily as an NMDA receptor antagonist, producing ketamine-like dissociative, analgesic, and anesthetic effects in preclinical models. Rapid hepatic metabolism yields active metabolites including nor-2F-DCK.

Key Product Specifications of 2F-DCK 50 mg Pellets

• Pellet size: Small, consistent 3–4 mm diameter
• Excipients: Inert binders for stability & accurate dosing
• Stability: Excellent cool/dark/dry storage (2+ years)
• Potency: 50 mg per pellet – common research dose (analog ranges: light 20–50 mg, common 50–100 mg, strong 100–150 mg oral/insufflated)

Research Effects & Characteristics

Duration: 2–5 hours Onset: 15–50 minutes Peak: 45–120 minutes

Preclinical and analog literature indicate ketamine-comparable dissociative effects: sedation, motor incoordination, analgesia, internal hallucinations, conceptual thinking, euphoria, perceptual distortions, time dilation, and dissociation (“k-hole” states at higher levels). Frequently described as similar in potency and duration to ketamine, with slightly smoother onset and potentially reduced bladder toxicity in models.

Possible side effects (dose-dependent, research observations): impaired consciousness, agitation, confusion, tachycardia, hypertension, nausea, nystagmus, hallucinations, respiratory depression risk, potential anxiety/paranoia, cardiovascular strain, rare neurotoxicity with high/repeated exposure.

2F-DCK 50 mg pellets are sold strictly for scientific research – not for human/veterinary use. Verify local regulations. Full CoA available.

Precision dissociative research with 2F-DCK from euro-labchems.com – your trusted specialist.